SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-23-074985
Filing Date
2023-09-07
Accepted
2023-09-07 16:15:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea184778-13dlinzeng_heyubio.htm SC 13D 43170
2 SHARE EXCHANGE AGREEMENT DATED AUGUST 21, 2023 ea184778ex99-1_heyubio.htm EX-99.1 227494
  Complete submission text file 0001213900-23-074985.txt   272185
Mailing Address 4TH FLOOR, NO.10 BUILDING, XINGLIN BAY BUSINESS OPERATION CENTER JIMEI DISTRICT XIAMEN CITY, FUJIAN PROVINCE F4 361022
Business Address 4TH FLOOR, NO.10 BUILDING, XINGLIN BAY BUSINESS OPERATION CENTER JIMEI DISTRICT XIAMEN CITY, FUJIAN PROVINCE F4 361022 86 158 5924 0902
Heyu Biological Technology Corp (Subject) CIK: 0001086303 (see all company filings)

IRS No.: 870627910 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-84989 | Film No.: 231242405
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 1008, BLOCK B, RONGSHANG BUILDING FUQING CITY F4 350309
Business Address
Lin Zengqiang (Filed by) CIK: 0001991791 (see all company filings)

Type: SC 13D